These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 10399884

  • 1. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor.
    Addo JK, Swamy N, Ray R.
    Steroids; 1999 Apr; 64(4):273-82. PubMed ID: 10399884
    [Abstract] [Full Text] [Related]

  • 2. Roles of the structure and orientation of ligands and ligand mimics inside the ligand-binding pocket of the vitamin D-binding protein.
    Swamy N, Dutta A, Ray R.
    Biochemistry; 1997 Jun 17; 36(24):7432-6. PubMed ID: 9200691
    [Abstract] [Full Text] [Related]

  • 3. Photoactivable analogs for labeling 25-hydroxyvitamin D3 serum binding protein and for 1,25-dihydroxyvitamin D3 intestinal receptor protein.
    Kutner A, Link RP, Schnoes HK, DeLuca HF.
    Bioorg Chem; 1986 Jun 17; 14():134-47. PubMed ID: 11540940
    [Abstract] [Full Text] [Related]

  • 4. Biological activity assessment of the 26,23-lactones of 1,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 and their binding properties to chick intestinal receptor and plasma vitamin D binding protein.
    Wilhelm F, Mayer E, Norman AW.
    Arch Biochem Biophys; 1984 Sep 17; 233(2):322-9. PubMed ID: 6091549
    [Abstract] [Full Text] [Related]

  • 5. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
    Skowronski RJ, Peehl DM, Feldman D.
    Endocrinology; 1995 Jan 17; 136(1):20-6. PubMed ID: 7530193
    [Abstract] [Full Text] [Related]

  • 6. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T, Nakagawa K, Tsugawa N, Ozono K, Kubodera N, Osawa A, Terada M, Mikami K.
    Biol Pharm Bull; 1998 Dec 17; 21(12):1300-5. PubMed ID: 9881643
    [Abstract] [Full Text] [Related]

  • 7. Binding properties of plasma vitamin D-binding protein and intestinal 1,25-dihydroxyvitamin D3 receptor in piglets with pseudo-vitamin D-deficiency rickets, type I: treatment effects with pharmacological doses of vitamin D3.
    Kaune R, Schroeder B, Harmeyer J.
    Arch Biochem Biophys; 1990 Nov 01; 282(2):326-32. PubMed ID: 2173481
    [Abstract] [Full Text] [Related]

  • 8. Fluoride substitution of vitamin D analogs at C-26 and C-27: enhancement of activity of 25-hydroxyvitamin D but not of 1,25-dihydroxyvitamin D on bone and intestine in vitro.
    Stern PH, Mavreas T, Tanaka Y, DeLuca HF, Ikekawa N, Kobayashi Y.
    J Pharmacol Exp Ther; 1984 Apr 01; 229(1):9-13. PubMed ID: 6323693
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and biological activities of 26-hydroxy-27-nor-derivatives of 1 alpha, 25-dihydroxyvitamin D3.
    Scheddin D, Mayer H, Wittmann S, Schönecker B, Gliesing S, Reichenbächer M.
    Steroids; 1996 Oct 01; 61(10):598-608. PubMed ID: 8910973
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
    Cross HS, Peterlik M, Reddy GS, Schuster I.
    J Steroid Biochem Mol Biol; 1997 May 01; 62(1):21-8. PubMed ID: 9366495
    [Abstract] [Full Text] [Related]

  • 11. Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease.
    Jolliffe DA, Stefanidis C, Wang Z, Kermani NZ, Dimitrov V, White JH, McDonough JE, Janssens W, Pfeffer P, Griffiths CJ, Bush A, Guo Y, Christenson S, Adcock IM, Chung KF, Thummel KE, Martineau AR.
    Am J Respir Crit Care Med; 2020 Aug 01; 202(3):371-382. PubMed ID: 32186892
    [Abstract] [Full Text] [Related]

  • 12. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
    Jung SJ, Lee YY, Pakkala S, de Vos S, Elstner E, Norman AW, Green J, Uskokovic M, Koeffler HP.
    Leuk Res; 1994 Jun 01; 18(6):453-63. PubMed ID: 8207963
    [Abstract] [Full Text] [Related]

  • 13. C-25 hydroxylation of 1alpha,24(R)-dihydroxyvitamin D3 is catalyzed by 25-hydroxyvitamin D3-24-hydroxylase (CYP24A1): metabolism studies with human keratinocytes and rat recombinant CYP24A1.
    Astecker N, Bobrovnikova EA, Omdahl JL, Gennaro L, Vouros P, Schuster I, Uskokovic MR, Ishizuka S, Wang G, Reddy GS.
    Arch Biochem Biophys; 2004 Nov 15; 431(2):261-70. PubMed ID: 15488475
    [Abstract] [Full Text] [Related]

  • 14. Production of 22-hydroxy metabolites of vitamin d3 by cytochrome p450scc (CYP11A1) and analysis of their biological activities on skin cells.
    Tuckey RC, Li W, Shehabi HZ, Janjetovic Z, Nguyen MN, Kim TK, Chen J, Howell DE, Benson HA, Sweatman T, Baldisseri DM, Slominski A.
    Drug Metab Dispos; 2011 Sep 15; 39(9):1577-88. PubMed ID: 21677063
    [Abstract] [Full Text] [Related]

  • 15. Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines.
    Masuda S, Kamao M, Schroeder NJ, Makin HL, Jones G, Kremer R, Rhim J, Okano T.
    Biol Pharm Bull; 2000 Feb 15; 23(2):133-9. PubMed ID: 10706373
    [Abstract] [Full Text] [Related]

  • 16. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.
    Kamao M, Tatematsu S, Hatakeyama S, Sakaki T, Sawada N, Inouye K, Ozono K, Kubodera N, Reddy GS, Okano T.
    J Biol Chem; 2004 Apr 16; 279(16):15897-907. PubMed ID: 14757768
    [Abstract] [Full Text] [Related]

  • 17. Affinity labeling of rat serum vitamin D binding protein.
    Swamy N, Ray R.
    Arch Biochem Biophys; 1996 Sep 01; 333(1):139-44. PubMed ID: 8806764
    [Abstract] [Full Text] [Related]

  • 18. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM, Bishop JE, Ishizuka S, Norman AW.
    Mol Endocrinol; 2000 Nov 01; 14(11):1788-96. PubMed ID: 11075812
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and binding-analysis of 5E-[19-(2-bromoacetoxy)methyl]25-hydroxyvitamin D3 and 5E-25-hydroxyvitamin D3-19-methyl[(4-azido-2-nitro)phenyl]glycinate: novel C19-modified affinity and photoaffinity analogs of 25-hydroxyvitamin D3.
    Addo JK, Ray R.
    Steroids; 1998 Apr 01; 63(4):218-23. PubMed ID: 9589557
    [Abstract] [Full Text] [Related]

  • 20. Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3.
    Miura D, Manabe K, Ozono K, Saito M, Gao Q, Norman AW, Ishizuka S.
    J Biol Chem; 1999 Jun 04; 274(23):16392-9. PubMed ID: 10347199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.